Course Director:
Huma Khan, RN, MSN

  
Overall Objectives:

• Identify indications for Bone Marrow Transplant and CAR T-Cell Therapy
• Recognize the toxicity profile of Bone Marrow Transplant and CAR T-Cell Therapy
• Comprehend patient outcomes of Bone Marrow Transplant and CAR T-Cell Therapy
• Identify alternatives to Bone Marrow Transplant and CAR T- Cell therapy

Target Audience:
Family Medicine, Hematology, Immunology, Infectious Disease, Internal Medicine, Medicine, Neurology, Oncology, Pathology and Physical Medicine & Rehabilitation

Accreditation Statement
Advocate Aurora Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation Statement
Advocate Aurora Health designates this live activity for a maximum of 1.00 AMA PRA Category 1 credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC Recognition Statement
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to
earn up to [1] Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Communication of MOC Recognition
This activity has been registered to offer 1.0 Lifelong Learning (Part II) credit in the American Board of Pathology’s (ABPath) Maintenance of Certification program. 

Participation information will be shared with the applicable Board through the Accreditation Council for Continuing Medical Education (ACCME) Program and Activity Reporting System (PARS).